Abstract
Due to an oversight of the corresponding author, the list of authors was originally published incorrectly in the manuscript entitled “Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease”, published in Current Alzheimer Research, volume 12, no. 4, 2015, pp. 298-313.
Due to this oversight, the correct first author was omitted from the original byline. The correct list of authors, with the true first author, is provided below:
Authors: Peter Cao, Nady Braidy, Martin Zarka, Jeffrey Welch and Wallace Bridge.
Affiliation: School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Syd-ney, Australia, NSW 2052.
Current Alzheimer Research
Title:Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease
Volume: 13 Issue: 10
Author(s):
Affiliation:
Abstract: Due to an oversight of the corresponding author, the list of authors was originally published incorrectly in the manuscript entitled “Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease”, published in Current Alzheimer Research, volume 12, no. 4, 2015, pp. 298-313.
Due to this oversight, the correct first author was omitted from the original byline. The correct list of authors, with the true first author, is provided below:
Authors: Peter Cao, Nady Braidy, Martin Zarka, Jeffrey Welch and Wallace Bridge.
Affiliation: School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Syd-ney, Australia, NSW 2052.
Export Options
About this article
Cite this article as:
, Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease, Current Alzheimer Research 2016; 13 (10) . https://dx.doi.org/10.2174/156720501310160825221218
DOI https://dx.doi.org/10.2174/156720501310160825221218 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications
Current Neuropharmacology Sulfur- and Acyl Chain-Dependent Influence of 2-Methoxy-Lysophosphatidylcholine Analogues on β Pancreatic Cells
Current Topics in Medicinal Chemistry Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer’s Disease
Central Nervous System Agents in Medicinal Chemistry The Monocyte Locomotion Inhibitory Factor an Anti-Inflammatory Peptide; Therapeutics Originating from Amebic Abscess of the Liver
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Targeted Genome Editing Tools for Disease Modeling and Gene Therapy
Current Gene Therapy Meet the Editorial Board Member
Current Neuropharmacology The Links between Cardiovascular Diseases and Alzheimer's Disease
Current Neuropharmacology Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications
Current Pharmacogenomics and Personalized Medicine Methotrexate-Induced Pneumonitis: Heterogeneity of Bronchoalveolar Lavage and Differences between Cancer and Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Ameliorative Effect of Trans-Sinapic Acid and its Protective Role in Cerebral Hypoxia in Aluminium Chloride Induced Dementia of Alzheimer's Type
CNS & Neurological Disorders - Drug Targets Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects
Current Alzheimer Research Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Current Topics in Medicinal Chemistry The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design Tanshinone IIA Protects Hippocampal Neuronal Cells from Reactive Oxygen Species Through Changes in Autophagy and Activation of Phosphatidylinositol 3-Kinase, Protein Kinas B, and Mechanistic Target of Rapamycin Pathways
Current Neurovascular Research Schizophrenia in an Adolescent with Complex Co-morbidity
Adolescent Psychiatry Different Food Odors Control Brain Connectivity in Impulsive Children
CNS & Neurological Disorders - Drug Targets Current Gene Expression Studies in Esophageal Carcinoma
Current Genomics The Bioanalytical Molecular Pharmacology of the N-methyl-<sub>D</sub>-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection
Current Molecular Pharmacology Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets